| | | |
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008
|
1
| EAP
| East Asia & Pacific
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 77.1579 | 77.6542 | 78.1522 | 78.6545 | 79.1594 | 79.5967 | 79.9645 | 80.3317 | 80.6981 | 81.0638 | 81.4208
|
2
| ECA
| Europe & Central Asia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 78.7426 | 78.8856 | 79.0228 | 79.1611 | 79.3090 | 79.5317 | 79.8242 | 80.1148 | 80.4031 | 80.6880 | 80.9545
|
3
| EMU
| Euro area
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 90.8954 | 91.1154 | 91.3362 | 91.5574 | 91.7794 | 91.9788 | 92.1544 | 92.3295 | 92.5046 | 92.6801 | 92.8121
|
4
| HIC
| High income
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 89.3180 | 89.5460 | 89.7755 | 90.0064 | 90.2386 | 90.4382 | 90.6030 | 90.7673 | 90.9325 | 91.0997 | 91.2392
|
5
| HPC
| Heavily indebted poor countries (HIPC)
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 48.3121 | 48.4992 | 48.6682 | 48.8298 | 49.0224 | 49.3480 | 49.7779 | 50.2086 | 50.6470 | 51.0874 | 51.6116
|
6
| LAC
| Latin America & Caribbean
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 79.4877 | 79.8438 | 80.2017 | 80.5587 | 80.9170 | 81.2518 | 81.5627 | 81.8739 | 82.1859 | 82.4976 | 82.7906
|
7
| LDC
| Least developed countries: UN classification
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 51.2115 | 51.7484 | 52.2685 | 52.7794 | 53.3141 | 53.8986 | 54.5075 | 55.1143 | 55.7248 | 56.3338 | 56.9611
|
8
| LIC
| Low income
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 56.1913 | 56.5135 | 56.7924 | 57.0981 | 57.4318 | 57.8768 | 58.4016 | 58.9260 | 59.4561 | 59.9876 | 60.5579
|
9
| LMC
| Lower middle income
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 70.8187 | 71.2973 | 71.7786 | 72.2650 | 72.7556 | 73.1971 | 73.5865 | 73.9724 | 74.3522 | 74.7274 | 75.1022
|
10
| LMY
| Low & middle income
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 70.1373 | 70.5060 | 70.8709 | 71.2385 | 71.6183 | 71.9936 | 72.3562 | 72.7164 | 73.0744 | 73.4294 | 73.7875
|
11
| MIC
| Middle income
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 72.5368 | 72.9331 | 73.3304 | 73.7305 | 74.1374 | 74.5194 | 74.8746 | 75.2279 | 75.5780 | 75.9255 | 76.2698
|
12
| MNA
| Middle East & North Africa
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 76.1107 | 76.6438 | 77.1750 | 77.7058 | 78.2360 | 78.6949 | 79.0849 | 79.4751 | 79.8637 | 80.2519 | 80.6484
|
13
| NOC
| High income: nonOECD
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 85.9707 | 86.2263 | 86.4860 | 86.7550 | 87.0162 | 87.2455 | 87.4709 | 87.6933 | 87.9243 | 88.1688 | 88.3721
|
14
| OEC
| High income: OECD
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 89.5139 | 89.7442 | 89.9751 | 90.2075 | 90.4410 | 90.6412 | 90.8054 | 90.9698 | 91.1345 | 91.3003 | 91.4395
|
15
| SAS
| South Asia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 61.6113 | 62.3003 | 62.9781 | 63.6506 | 64.3432 | 65.0048 | 65.6145 | 66.2210 | 66.8291 | 67.4349 | 68.0327
|
16
| SSA
| Sub-Saharan Africa
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 46.8403 | 46.6297 | 46.4215 | 46.2141 | 46.0208 | 46.0609 | 46.3397 | 46.6245 | 46.9162 | 47.2147 | 47.6434
|
17
| UMC
| Upper middle income
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 78.5898 | 78.7098 | 78.8244 | 78.9449 | 79.0842 | 79.2827 | 79.5427 | 79.8026 | 80.0646 | 80.3274 | 80.5717
|
18
| WLD
| World
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 73.5544 | 73.8625 | 74.1688 | 74.4786 | 74.8001 | 75.1133 | 75.4115 | 75.7093 | 76.0082 | 76.3081 | 76.6057
|
19
| AFG
| Afghanistan
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 32.6265 | 32.7094 | 32.7924 | 32.8754 | 32.9584 | 33.2353 | 33.7063 | 34.1773 | 34.6482 | 35.1192 | 35.5838
|
20
| ALB
| Albania
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 86.8486 | 87.4211 | 87.9935 | 88.5660 | 89.1384 | 89.4909 | 89.6234 | 89.7559 | 89.8884 | 90.0209 | 90.1459
|
21
| DZA
| Algeria
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 76.2402 | 76.8225 | 77.4047 | 77.9870 | 78.5692 | 79.1029 | 79.5881 | 80.0733 | 80.5585 | 81.0437 | 81.5003
|
22
| ASM
| American Samoa
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
23
| ADO
| Andorra
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
24
| AGO
| Angola
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 38.5534 | 38.9087 | 39.2641 | 39.6194 | 39.9747 | 40.4674 | 41.0974 | 41.7274 | 42.3573 | 42.9873 | 43.6182
|
25
| ATG
| Antigua and Barbuda
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
26
| ARG
| Argentina
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 84.8361 | 85.0365 | 85.2369 | 85.4374 | 85.6378 | 85.8599 | 86.1037 | 86.3475 | 86.5913 | 86.8351 | 87.0657
|
27
| ARM
| Armenia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 79.7002 | 80.4407 | 81.1812 | 81.9217 | 82.6622 | 83.1831 | 83.4843 | 83.7856 | 84.0869 | 84.3881 | 84.6585
|
28
| ABW
| Aruba
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 85.3962 | 85.4980 | 85.5998 | 85.7016 | 85.8035 | 85.9479 | 86.1350 | 86.3220 | 86.5090 | 86.6961 | 86.8635
|
29
| AUS
| Australia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 91.2211 | 91.4774 | 91.7337 | 91.9900 | 92.2463 | 92.4320 | 92.5471 | 92.6623 | 92.7775 | 92.8926 | 92.9936
|
30
| AUT
| Austria
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 90.6911 | 90.9671 | 91.2432 | 91.5192 | 91.7953 | 92.0027 | 92.1416 | 92.2804 | 92.4193 | 92.5581 | 92.6683
|
31
| AZE
| Azerbaijan
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 75.7337 | 75.9006 | 76.0675 | 76.2344 | 76.4013 | 76.6820 | 77.0766 | 77.4712 | 77.8658 | 78.2604 | 78.6134
|
32
| BHS
| Bahamas The
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 75.9460 | 76.3550 | 76.7640 | 77.1729 | 77.5819 | 78.0700 | 78.6373 | 79.2047 | 79.7720 | 80.3393 | 80.9346
|
33
| BHR
| Bahrain
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 85.0859 | 85.2668 | 85.4478 | 85.6288 | 85.8097 | 86.0169 | 86.2504 | 86.4839 | 86.7174 | 86.9509 | 87.1627
|
34
| BGD
| Bangladesh
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 59.9409 | 61.0706 | 62.2003 | 63.3299 | 64.4596 | 65.5221 | 66.5174 | 67.5127 | 68.5080 | 69.5033 | 70.3330
|
35
| BRB
| Barbados
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 87.7276 | 87.8944 | 88.0613 | 88.2282 | 88.3950 | 88.5650 | 88.7381 | 88.9112 | 89.0843 | 89.2574 | 89.4170
|
36
| BLR
| Belarus
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 80.6936 | 80.8253 | 80.9570 | 81.0888 | 81.2205 | 81.4084 | 81.6526 | 81.8967 | 82.1409 | 82.3850 | 82.6206
|
37
| BEL
| Belgium
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 90.1472 | 90.3325 | 90.5179 | 90.7032 | 90.8886 | 91.0961 | 91.3258 | 91.5555 | 91.7852 | 92.0149 | 92.2247
|
38
| BLZ
| Belize
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 82.7754 | 82.8191 | 82.8628 | 82.9065 | 82.9501 | 83.1821 | 83.6024 | 84.0226 | 84.4429 | 84.8631 | 85.2668
|
39
| BEN
| Benin
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 61.4632 | 61.8578 | 62.2524 | 62.6470 | 63.0416 | 63.5566 | 64.1919 | 64.8272 | 65.4624 | 66.0977 | 66.7441
|
40
| BMU
| Bermuda
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
41
| BTN
| Bhutan
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 61.4283 | 62.8006 | 64.1728 | 65.5450 | 66.9172 | 67.9891 | 68.7608 | 69.5324 | 70.3041 | 71.0757 | 71.7837
|
42
| BOL
| Bolivia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 66.6671 | 67.1762 | 67.6852 | 68.1943 | 68.7034 | 69.1738 | 69.6055 | 70.0373 | 70.4691 | 70.9009 | 71.3439
|
43
| BIH
| Bosnia and Herzegovina
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 84.2382 | 84.5185 | 84.7988 | 85.0792 | 85.3595 | 85.8473 | 86.5425 | 87.2377 | 87.9329 | 88.6281 | 89.0368
|
44
| BWA
| Botswana
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 51.4609 | 48.0679 | 44.6749 | 41.2820 | 37.8890 | 36.9612 | 38.4985 | 40.0358 | 41.5731 | 43.1104 | 43.5819
|
45
| BRA
| Brazil
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 76.8094 | 77.1713 | 77.5332 | 77.8951 | 78.2570 | 78.6128 | 78.9625 | 79.3123 | 79.6620 | 80.0118 | 80.3568
|
46
| BRN
| Brunei Darussalam
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 86.8385 | 87.0387 | 87.2389 | 87.4390 | 87.6392 | 87.8351 | 88.0267 | 88.2182 | 88.4098 | 88.6013 | 88.7851
|
47
| BGR
| Bulgaria
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 83.6299 | 83.9023 | 84.1746 | 84.4470 | 84.7193 | 85.0147 | 85.3331 | 85.6516 | 85.9700 | 86.2884 | 86.5557
|
48
| BFA
| Burkina Faso
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 45.1717 | 45.7624 | 46.3532 | 46.9439 | 47.5347 | 48.1347 | 48.7441 | 49.3534 | 49.9627 | 50.5720 | 51.1539
|
49
| BDI
| Burundi
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 40.2512 | 40.6739 | 41.0966 | 41.5193 | 41.9420 | 42.5431 | 43.3227 | 44.1022 | 44.8818 | 45.6613 | 46.4168
|
50
| KHM
| Cambodia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 56.3890 | 56.9064 | 57.4237 | 57.9411 | 58.4585 | 59.1348 | 59.9700 | 60.8053 | 61.6405 | 62.4758 | 63.2880
|
51
| CMR
| Cameroon
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 49.5676 | 48.6185 | 47.6693 | 46.7202 | 45.7710 | 45.1951 | 44.9924 | 44.7897 | 44.5870 | 44.3842 | 44.5410
|
52
| CAN
| Canada
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 90.2011 | 90.3716 | 90.5421 | 90.7126 | 90.8830 | 91.0327 | 91.1616 | 91.2904 | 91.4193 | 91.5481 | 91.6680
|
53
| CPV
| Cape Verde
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 76.2861 | 76.8224 | 77.3586 | 77.8949 | 78.4311 | 78.9670 | 79.5024 | 80.0378 | 80.5732 | 81.1087 | 81.6034
|
54
| CYM
| Cayman Islands
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
55
| CAF
| Central African Republic
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 43.8468 | 43.0520 | 42.2572 | 41.4624 | 40.6677 | 40.2713 | 40.2735 | 40.2756 | 40.2777 | 40.2798 | 40.4649
|
56
| TCD
| Chad
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 50.5251 | 49.9105 | 49.2960 | 48.6815 | 48.0670 | 47.6810 | 47.5237 | 47.3663 | 47.2090 | 47.0516 | 47.1402
|
57
| CHI
| Channel Islands
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 91.3639 | 91.4824 | 91.6009 | 91.7195 | 91.8380 | 91.9451 | 92.0408 | 92.1365 | 92.2322 | 92.3279 | 92.4199
|
58
| CHL
| Chile
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 86.7150 | 87.1933 | 87.6716 | 88.1499 | 88.6282 | 88.9545 | 89.1290 | 89.3035 | 89.4780 | 89.6524 | 89.8170
|
59
| CHN
| China
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 78.7126 | 79.2016 | 79.6907 | 80.1798 | 80.6688 | 81.0747 | 81.3974 | 81.7201 | 82.0428 | 82.3655 | 82.6682
|
60
| COL
| Colombia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 80.4337 | 80.7572 | 81.0807 | 81.4042 | 81.7276 | 82.0575 | 82.3939 | 82.7302 | 83.0665 | 83.4028 | 83.6995
|
61
| COM
| Comoros
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 63.4273 | 64.2048 | 64.9822 | 65.7597 | 66.5372 | 67.2988 | 68.0445 | 68.7902 | 69.5360 | 70.2817 | 71.0028
|
62
| ZAR
| Congo Dem. Rep.
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 41.1515 | 41.7604 | 42.3693 | 42.9782 | 43.5871 | 43.8508 | 43.7693 | 43.6877 | 43.6062 | 43.5246 | 43.6763
|
63
| COG
| Congo Rep.
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 51.5648 | 50.9391 | 50.3134 | 49.6878 | 49.0621 | 48.7787 | 48.8377 | 48.8966 | 48.9556 | 49.0145 | 49.2355
|
64
| CRI
| Costa Rica
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 87.9769 | 88.1663 | 88.3556 | 88.5450 | 88.7344 | 88.9090 | 89.0690 | 89.2289 | 89.3888 | 89.5487 | 89.6994
|
65
| CIV
| Cote d'Ivoire
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 59.3636 | 58.5830 | 57.8024 | 57.0217 | 56.2411 | 56.0626 | 56.4862 | 56.9098 | 57.3333 | 57.7569 | 58.3586
|
66
| HRV
| Croatia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 88.2215 | 88.2866 | 88.3517 | 88.4169 | 88.4820 | 88.6299 | 88.8606 | 89.0914 | 89.3221 | 89.5529 | 89.7445
|
67
| CUB
| Cuba
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 85.9753 | 86.2047 | 86.4341 | 86.6634 | 86.8928 | 87.1774 | 87.5173 | 87.8572 | 88.1971 | 88.5370 | 88.7679
|
68
| CYP
| Cyprus
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 91.7702 | 91.8932 | 92.0162 | 92.1392 | 92.2623 | 92.3654 | 92.4487 | 92.5320 | 92.6153 | 92.6986 | 92.7740
|
69
| CZE
| Czech Republic
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 87.9478 | 88.1879 | 88.4279 | 88.6679 | 88.9080 | 89.1131 | 89.2835 | 89.4538 | 89.6241 | 89.7945 | 89.9538
|
70
| DNK
| Denmark
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 86.0744 | 86.3634 | 86.6525 | 86.9416 | 87.2306 | 87.5062 | 87.7681 | 88.0301 | 88.2921 | 88.5541 | 88.7723
|
71
| DJI
| Djibouti
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 51.2703 | 51.3087 | 51.3471 | 51.3854 | 51.4238 | 51.5978 | 51.9074 | 52.2170 | 52.5267 | 52.8363 | 53.2381
|
72
| DMA
| Dominica
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
73
| DOM
| Dominican Republic
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 75.2364 | 75.6370 | 76.0375 | 76.4380 | 76.8385 | 77.1857 | 77.4796 | 77.7734 | 78.0673 | 78.3612 | 78.6346
|
74
| ECU
| Ecuador
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 81.7204 | 82.3083 | 82.8963 | 83.4842 | 84.0721 | 84.4619 | 84.6534 | 84.8450 | 85.0365 | 85.2281 | 85.4132
|
75
| EGY
| Egypt Arab Rep.
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 75.0994 | 75.7274 | 76.3553 | 76.9832 | 77.6112 | 78.1139 | 78.4915 | 78.8691 | 79.2466 | 79.6242 | 80.0033
|
76
| SLV
| El Salvador
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 77.5458 | 77.8378 | 78.1298 | 78.4219 | 78.7139 | 79.0054 | 79.2965 | 79.5876 | 79.8786 | 80.1697 | 80.4681
|
77
| GNQ
| Equatorial Guinea
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 45.6242 | 45.4358 | 45.2473 | 45.0589 | 44.8705 | 44.8818 | 45.0928 | 45.3038 | 45.5149 | 45.7259 | 46.1261
|
78
| ERI
| Eritrea
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 49.1473 | 50.1269 | 51.1064 | 52.0860 | 53.0656 | 53.9125 | 54.6268 | 55.3411 | 56.0554 | 56.7698 | 57.4722
|
79
| EST
| Estonia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 82.4480 | 82.9446 | 83.4411 | 83.9376 | 84.4341 | 84.8779 | 85.2689 | 85.6600 | 86.0510 | 86.4421 | 86.7415
|
80
| ETH
| Ethiopia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 47.9812 | 48.4324 | 48.8836 | 49.3348 | 49.7860 | 50.3500 | 51.0266 | 51.7032 | 52.3798 | 53.0564 | 53.7201
|
81
| FRO
| Faeroe Islands
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
82
| FJI
| Fiji
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 71.0983 | 71.4886 | 71.8790 | 72.2693 | 72.6597 | 73.0456 | 73.4270 | 73.8084 | 74.1899 | 74.5713 | 74.9375
|
83
| FIN
| Finland
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 91.0821 | 91.2788 | 91.4756 | 91.6723 | 91.8691 | 92.0640 | 92.2570 | 92.4500 | 92.6431 | 92.8361 | 92.9741
|
84
| FRA
| France
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 91.4448 | 91.5975 | 91.7501 | 91.9028 | 92.0554 | 92.2524 | 92.4936 | 92.7349 | 92.9762 | 93.2174 | 93.3711
|
85
| PYF
| French Polynesia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 80.0173 | 80.6128 | 81.2082 | 81.8037 | 82.3991 | 82.8342 | 83.1089 | 83.3836 | 83.6583 | 83.9330 | 84.2014
|
86
| GAB
| Gabon
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 63.6357 | 62.8831 | 62.1304 | 61.3778 | 60.6252 | 60.2592 | 60.2798 | 60.3003 | 60.3209 | 60.3415 | 60.5920
|
87
| GMB
| Gambia The
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 50.5673 | 50.9734 | 51.3795 | 51.7857 | 52.1918 | 52.5952 | 52.9958 | 53.3965 | 53.7971 | 54.1977 | 54.7536
|
88
| GEO
| Georgia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 83.6413 | 83.7553 | 83.8692 | 83.9831 | 84.0971 | 84.1540 | 84.1540 | 84.1540 | 84.1540 | 84.1540 | 84.2685
|
89
| DEU
| Germany
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 90.0964 | 90.3226 | 90.5489 | 90.7751 | 91.0013 | 91.1985 | 91.3665 | 91.5346 | 91.7026 | 91.8707 | 92.0046
|
90
| GHA
| Ghana
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 58.6511 | 58.0944 | 57.5377 | 56.9810 | 56.4243 | 56.0115 | 55.7426 | 55.4737 | 55.2048 | 54.9359 | 55.0356
|
91
| GRC
| Greece
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 90.8589 | 91.2548 | 91.6507 | 92.0465 | 92.4424 | 92.7172 | 92.8709 | 93.0247 | 93.1784 | 93.3322 | 93.4718
|
92
| GRL
| Greenland
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
93
| GRD
| Grenada
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 82.1669 | 82.7180 | 83.2692 | 83.8203 | 84.3714 | 84.7917 | 85.0811 | 85.3704 | 85.6598 | 85.9492 | 86.2069
|
94
| GUM
| Guam
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 87.0379 | 87.2513 | 87.4648 | 87.6783 | 87.8918 | 88.0867 | 88.2630 | 88.4393 | 88.6156 | 88.7919 | 88.9545
|
95
| GTM
| Guatemala
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 74.3289 | 75.0893 | 75.8497 | 76.6100 | 77.3704 | 77.8945 | 78.1823 | 78.4702 | 78.7580 | 79.0459 | 79.3261
|
96
| GIN
| Guinea
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 54.2850 | 55.1712 | 56.0573 | 56.9435 | 57.8296 | 58.6797 | 59.4939 | 60.3080 | 61.1221 | 61.9363 | 62.6954
|
97
| GNB
| Guinea-Bissau
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 41.1643 | 41.4526 | 41.7410 | 42.0293 | 42.3177 | 42.5913 | 42.8503 | 43.1092 | 43.3681 | 43.6270 | 44.0124
|
98
| GUY
| Guyana
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 67.6716 | 67.9684 | 68.2653 | 68.5622 | 68.8590 | 69.4390 | 70.3022 | 71.1653 | 72.0285 | 72.8916 | 73.6531
|
99
| HTI
| Haiti
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 60.9590 | 61.2815 | 61.6039 | 61.9264 | 62.2489 | 62.5408 | 62.8023 | 63.0637 | 63.3251 | 63.5865 | 63.8724
|
100
| HND
| Honduras
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 76.8015 | 77.1364 | 77.4713 | 77.8062 | 78.1411 | 78.4671 | 78.7841 | 79.1011 | 79.4181 | 79.7350 | 80.0341
|
101
| HKG
| Hong Kong SAR China
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 92.6492 | 92.8599 | 93.0705 | 93.2811 | 93.4918 | 93.6378 | 93.7193 | 93.8008 | 93.8822 | 93.9637 | 94.0379
|
102
| HUN
| Hungary
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 82.2758 | 82.7467 | 83.2176 | 83.6885 | 84.1594 | 84.5172 | 84.7620 | 85.0067 | 85.2515 | 85.4963 | 85.7358
|
103
| ISL
| Iceland
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 91.4045 | 91.6263 | 91.8481 | 92.0700 | 92.2918 | 92.4401 | 92.5150 | 92.5899 | 92.6647 | 92.7396 | 92.8200
|
104
| IND
| India
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 61.5017 | 62.1305 | 62.7593 | 63.3882 | 64.0170 | 64.6190 | 65.1941 | 65.7693 | 66.3445 | 66.9196 | 67.5121
|
105
| IDN
| Indonesia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 71.9083 | 72.7639 | 73.6195 | 74.4751 | 75.3307 | 76.1441 | 76.9151 | 77.6862 | 78.4573 | 79.2283 | 79.9105
|
106
| IRN
| Iran Islamic Rep.
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 75.9611 | 76.5850 | 77.2090 | 77.8329 | 78.4569 | 79.0145 | 79.5058 | 79.9972 | 80.4885 | 80.9799 | 81.4680
|
107
| IRQ
| Iraq
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 82.4760 | 82.3256 | 82.1751 | 82.0247 | 81.8742 | 81.6824 | 81.4493 | 81.2162 | 80.9831 | 80.7500 | 80.7882
|
108
| IRL
| Ireland
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 88.5822 | 88.8918 | 89.2015 | 89.5112 | 89.8208 | 90.1561 | 90.5169 | 90.8776 | 91.2384 | 91.5992 | 91.8326
|
109
| IMY
| Isle of Man
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
110
| ISR
| Israel
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 91.1944 | 91.4384 | 91.6823 | 91.9263 | 92.1703 | 92.3662 | 92.5141 | 92.6621 | 92.8100 | 92.9580 | 93.0692
|
111
| ITA
| Italy
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 91.5858 | 91.8503 | 92.1149 | 92.3795 | 92.6440 | 92.8459 | 92.9850 | 93.1241 | 93.2633 | 93.4024 | 93.5047
|
112
| JAM
| Jamaica
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 79.6265 | 79.6700 | 79.7136 | 79.7572 | 79.8008 | 79.9287 | 80.1411 | 80.3535 | 80.5659 | 80.7783 | 81.0057
|
113
| JPN
| Japan
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 93.0149 | 93.2014 | 93.3879 | 93.5744 | 93.7609 | 93.9117 | 94.0267 | 94.1417 | 94.2568 | 94.3718 | 94.4882
|
114
| JOR
| Jordan
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 75.5494 | 76.1404 | 76.7314 | 77.3225 | 77.9135 | 78.4766 | 79.0118 | 79.5469 | 80.0821 | 80.6173 | 81.0940
|
115
| KAZ
| Kazakhstan
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 71.5421 | 71.9794 | 72.4168 | 72.8541 | 73.2915 | 73.6926 | 74.0573 | 74.4221 | 74.7869 | 75.1517 | 75.4858
|
116
| KEN
| Kenya
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 52.0864 | 50.2592 | 48.4320 | 46.6048 | 44.7776 | 44.1515 | 44.7266 | 45.3016 | 45.8767 | 46.4517 | 47.2185
|
117
| KIR
| Kiribati
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
118
| PRK
| Korea Dem. Rep.
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 78.8725 | 78.0090 | 77.1454 | 76.2819 | 75.4184 | 75.0816 | 75.2717 | 75.4618 | 75.6519 | 75.8420 | 76.1384
|
119
| KOR
| Korea Rep.
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 87.7533 | 88.5562 | 89.3591 | 90.1620 | 90.9649 | 91.4899 | 91.7369 | 91.9839 | 92.2309 | 92.4780 | 92.6444
|
120
| KSV
| Kosovo
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
121
| KWT
| Kuwait
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 87.9633 | 88.1612 | 88.3591 | 88.5569 | 88.7548 | 88.9219 | 89.0583 | 89.1947 | 89.3311 | 89.4675 | 89.6003
|
122
| KGZ
| Kyrgyz Republic
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 75.0916 | 75.2247 | 75.3577 | 75.4908 | 75.6238 | 75.8524 | 76.1764 | 76.5005 | 76.8246 | 77.1487 | 77.4945
|
123
| LAO
| Lao PDR
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 60.5548 | 61.4053 | 62.2558 | 63.1063 | 63.9568 | 64.8119 | 65.6716 | 66.5312 | 67.3908 | 68.2505 | 69.0465
|
124
| LVA
| Latvia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 81.4119 | 81.9244 | 82.4369 | 82.9494 | 83.4619 | 83.8665 | 84.1632 | 84.4599 | 84.7566 | 85.0533 | 85.3231
|
125
| LBN
| Lebanon
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 79.3175 | 79.6092 | 79.9010 | 80.1928 | 80.4845 | 80.8007 | 81.1414 | 81.4821 | 81.8228 | 82.1635 | 82.4874
|
126
| LSO
| Lesotho
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 52.9045 | 49.0283 | 45.1520 | 41.2758 | 37.3995 | 34.8790 | 33.7141 | 32.5492 | 31.3843 | 30.2195 | 29.5647
|
127
| LBR
| Liberia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 55.6216 | 56.3535 | 57.0855 | 57.8174 | 58.5494 | 59.1926 | 59.7471 | 60.3017 | 60.8562 | 61.4108 | 61.9832
|
128
| LBY
| Libya
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 80.4006 | 80.7706 | 81.1405 | 81.5105 | 81.8804 | 82.2422 | 82.5957 | 82.9493 | 83.3028 | 83.6564 | 83.9725
|
129
| LIE
| Liechtenstein
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
130
| LTU
| Lithuania
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 83.8793 | 84.3276 | 84.7759 | 85.2242 | 85.6725 | 85.9231 | 85.9759 | 86.0288 | 86.0816 | 86.1345 | 86.2463
|
131
| LUX
| Luxembourg
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 90.1865 | 90.3547 | 90.5230 | 90.6913 | 90.8596 | 91.0250 | 91.1873 | 91.3497 | 91.5121 | 91.6745 | 91.8060
|
132
| MAC
| Macao SAR China
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 90.6360 | 90.7406 | 90.8453 | 90.9500 | 91.0547 | 91.2193 | 91.4437 | 91.6682 | 91.8927 | 92.1171 | 92.2767
|
133
| MKD
| Macedonia FYR
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 82.7442 | 83.0816 | 83.4190 | 83.7565 | 84.0939 | 84.3569 | 84.5455 | 84.7341 | 84.9227 | 85.1113 | 85.2981
|
134
| MDG
| Madagascar
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 55.1788 | 55.9108 | 56.6429 | 57.3749 | 58.1070 | 58.8530 | 59.6129 | 60.3728 | 61.1327 | 61.8926 | 62.6131
|
135
| MWI
| Malawi
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 53.0258 | 51.6275 | 50.2292 | 48.8310 | 47.4327 | 46.8514 | 47.0870 | 47.3226 | 47.5583 | 47.7939 | 48.3592
|
136
| MYS
| Malaysia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 81.6116 | 81.9337 | 82.2558 | 82.5779 | 82.9000 | 83.2430 | 83.6068 | 83.9707 | 84.3346 | 84.6985 | 85.0093
|
137
| MDV
| Maldives
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 67.6654 | 69.1773 | 70.6893 | 72.2012 | 73.7131 | 75.0265 | 76.1412 | 77.2559 | 78.3705 | 79.4852 | 80.4054
|
138
| MLI
| Mali
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 36.4905 | 36.9506 | 37.4106 | 37.8707 | 38.3307 | 38.8315 | 39.3730 | 39.9146 | 40.4561 | 40.9976 | 41.5641
|
139
| MLT
| Malta
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 89.4855 | 89.6868 | 89.8881 | 90.0894 | 90.2907 | 90.4413 | 90.5412 | 90.6411 | 90.7410 | 90.8409 | 90.9520
|
140
| MHL
| Marshall Islands
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
141
| MRT
| Mauritania
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 57.2191 | 57.2596 | 57.3000 | 57.3405 | 57.3810 | 57.4181 | 57.4518 | 57.4854 | 57.5191 | 57.5528 | 57.9050
|
142
| MUS
| Mauritius
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 79.7536 | 79.9702 | 80.1868 | 80.4034 | 80.6200 | 80.7911 | 80.9166 | 81.0422 | 81.1678 | 81.2934 | 81.3714
|
143
| MYT
| Mayotte
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | 89.4482 | 89.5744 | 89.6811 | 89.7878 | 89.8946 | 90.0013 | 90.1005
|
144
| MEX
| Mexico
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 83.0804 | 83.4377 | 83.7951 | 84.1524 | 84.5097 | 84.8411 | 85.1464 | 85.4518 | 85.7572 | 86.0625 | 86.3420
|
145
| FSM
| Micronesia Fed. Sts.
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 71.0831 | 71.2818 | 71.4806 | 71.6793 | 71.8781 | 72.1651 | 72.5404 | 72.9156 | 73.2909 | 73.6661 | 74.0319
|
146
| MDA
| Moldova
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 74.5558 | 74.8640 | 75.1721 | 75.4802 | 75.7884 | 76.1388 | 76.5313 | 76.9239 | 77.3164 | 77.7090 | 78.0555
|
147
| MCO
| Monaco
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
148
| MNG
| Mongolia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 63.8813 | 64.4166 | 64.9520 | 65.4874 | 66.0227 | 66.6938 | 67.5005 | 68.3072 | 69.1140 | 69.9207 | 70.5942
|
149
| MNE
| Montenegro
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 87.1866 | 86.4823 | 85.7781 | 85.0738 | 84.3696 | 84.1330 | 84.3642 | 84.5954 | 84.8266 | 85.0578 | 85.3060
|
150
| MAR
| Morocco
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 76.6330 | 77.2509 | 77.8688 | 78.4867 | 79.1047 | 79.6758 | 80.2001 | 80.7245 | 81.2488 | 81.7732 | 82.2498
|
151
| MOZ
| Mozambique
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 43.6175 | 43.3890 | 43.1606 | 42.9322 | 42.7037 | 42.3108 | 41.7533 | 41.1958 | 40.6383 | 40.0809 | 39.7047
|
152
| MMR
| Myanmar
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 61.4897 | 61.7990 | 62.1083 | 62.4176 | 62.7269 | 63.0212 | 63.3003 | 63.5795 | 63.8587 | 64.1379 | 64.8123
|
153
| NAM
| Namibia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 63.4558 | 61.1101 | 58.7644 | 56.4186 | 54.0729 | 53.5425 | 54.8273 | 56.1122 | 57.3970 | 58.6819 | 59.1343
|
154
| NPL
| Nepal
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 59.2507 | 60.5623 | 61.8739 | 63.1855 | 64.4971 | 65.6671 | 66.6955 | 67.7239 | 68.7523 | 69.7807 | 70.5959
|
155
| NLD
| Netherlands
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 90.0103 | 90.1415 | 90.2727 | 90.4039 | 90.5351 | 90.6967 | 90.8887 | 91.0807 | 91.2727 | 91.4647 | 91.6098
|
156
| ANT
| Netherlands Antilles
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 85.6471 | 85.8514 | 86.0558 | 86.2602 | 86.4646 | 86.6089 | 86.6933 | 86.7776 | 86.8620 | 86.9464 | 87.0532
|
157
| NCL
| New Caledonia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 83.3632 | 84.1085 | 84.8539 | 85.5992 | 86.3446 | 86.8430 | 87.0946 | 87.3462 | 87.5977 | 87.8493 | 88.0706
|
158
| NZL
| New Zealand
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 88.8667 | 89.1287 | 89.3908 | 89.6528 | 89.9148 | 90.1251 | 90.2837 | 90.4423 | 90.6008 | 90.7594 | 90.9041
|
159
| NIC
| Nicaragua
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 74.5661 | 75.2214 | 75.8766 | 76.5319 | 77.1871 | 77.8376 | 78.4833 | 79.1290 | 79.7747 | 80.4204 | 80.9895
|
160
| NER
| Niger
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 39.5796 | 40.4210 | 41.2623 | 42.1037 | 42.9451 | 43.7693 | 44.5765 | 45.3838 | 46.1910 | 46.9982 | 47.8798
|
161
| NGA
| Nigeria
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 39.6961 | 39.9254 | 40.1548 | 40.3841 | 40.6134 | 40.8291 | 41.0312 | 41.2333 | 41.4354 | 41.6376 | 41.9075
|
162
| MNP
| Northern Mariana Islands
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
163
| NOR
| Norway
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 90.8024 | 90.9480 | 91.0936 | 91.2392 | 91.3848 | 91.5360 | 91.6927 | 91.8494 | 92.0062 | 92.1629 | 92.2855
|
164
| OMN
| Oman
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 82.6235 | 83.1334 | 83.6433 | 84.1531 | 84.6630 | 85.1186 | 85.5199 | 85.9213 | 86.3226 | 86.7239 | 87.0360
|
165
| PAK
| Pakistan
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 66.3802 | 66.8569 | 67.3335 | 67.8101 | 68.2867 | 68.7618 | 69.2355 | 69.7092 | 70.1828 | 70.6565 | 71.1418
|
166
| PLW
| Palau
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
167
| PAN
| Panama
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 84.9805 | 85.2102 | 85.4399 | 85.6697 | 85.8994 | 86.1100 | 86.3017 | 86.4934 | 86.6850 | 86.8767 | 87.0606
|
168
| PNG
| Papua New Guinea
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 55.1096 | 55.5866 | 56.0636 | 56.5406 | 57.0176 | 57.5485 | 58.1332 | 58.7180 | 59.3027 | 59.8874 | 60.4598
|
169
| PRY
| Paraguay
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 76.7115 | 76.9744 | 77.2374 | 77.5003 | 77.7633 | 78.0307 | 78.3025 | 78.5744 | 78.8463 | 79.1181 | 79.3891
|
170
| PER
| Peru
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 77.3550 | 78.0550 | 78.7550 | 79.4550 | 80.1550 | 80.6961 | 81.0781 | 81.4602 | 81.8423 | 82.2244 | 82.5409
|
171
| PHL
| Philippines
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 76.4541 | 77.1086 | 77.7631 | 78.4176 | 79.0721 | 79.6574 | 80.1735 | 80.6896 | 81.2057 | 81.7218 | 82.1900
|
172
| POL
| Poland
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 86.0053 | 86.4419 | 86.8785 | 87.3151 | 87.7516 | 88.0799 | 88.2998 | 88.5197 | 88.7395 | 88.9594 | 89.1401
|
173
| PRT
| Portugal
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 89.9000 | 90.2217 | 90.5434 | 90.8650 | 91.1867 | 91.4303 | 91.5957 | 91.7612 | 91.9266 | 92.0921 | 92.2221
|
174
| PRI
| Puerto Rico
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 87.4994 | 88.0787 | 88.6580 | 89.2373 | 89.8165 | 90.1889 | 90.3544 | 90.5199 | 90.6855 | 90.8510 | 90.9874
|
175
| QAT
| Qatar
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 78.9619 | 79.4013 | 79.8408 | 80.2803 | 80.7197 | 81.1302 | 81.5117 | 81.8931 | 82.2746 | 82.6561 | 82.9910
|
176
| ROM
| Romania
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 81.4460 | 81.9640 | 82.4821 | 83.0001 | 83.5181 | 83.9268 | 84.2263 | 84.5258 | 84.8252 | 85.1247 | 85.3994
|
177
| RUS
| Russian Federation
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 77.1171 | 76.8659 | 76.6148 | 76.3636 | 76.1124 | 76.1838 | 76.5777 | 76.9715 | 77.3654 | 77.7593 | 78.1224
|
178
| RWA
| Rwanda
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 29.5333 | 31.5742 | 33.6150 | 35.6558 | 37.6967 | 39.3954 | 40.7522 | 42.1089 | 43.4656 | 44.8223 | 45.8484
|
179
| WSM
| Samoa
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 76.0967 | 76.6493 | 77.2018 | 77.7544 | 78.3069 | 78.8103 | 79.2644 | 79.7185 | 80.1726 | 80.6267 | 81.0277
|
180
| SMR
| San Marino
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
181
| STP
| Sao Tome and Principe
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 71.0435 | 71.4185 | 71.7934 | 72.1684 | 72.5434 | 72.9304 | 73.3295 | 73.7287 | 74.1278 | 74.5269 | 74.9130
|
182
| SAU
| Saudi Arabia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 79.9293 | 80.3810 | 80.8327 | 81.2844 | 81.7361 | 82.1766 | 82.6059 | 83.0351 | 83.4644 | 83.8936 | 84.2499
|
183
| SEN
| Senegal
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 50.9651 | 51.2600 | 51.5549 | 51.8497 | 52.1446 | 52.4419 | 52.7416 | 53.0414 | 53.3411 | 53.6408 | 54.1486
|
184
| SRB
| Serbia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 82.9243 | 83.2372 | 83.5501 | 83.8630 | 84.1760 | 84.4359 | 84.6428 | 84.8498 | 85.0567 | 85.2636 | 85.4604
|
185
| SYC
| Seychelles
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
186
| SLE
| Sierra Leone
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 25.3683 | 26.1473 | 26.9262 | 27.7052 | 28.4841 | 29.2471 | 29.9942 | 30.7413 | 31.4884 | 32.2355 | 32.9436
|
187
| SGP
| Singapore
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 89.5507 | 89.8377 | 90.1248 | 90.4118 | 90.6988 | 91.0068 | 91.3358 | 91.6648 | 91.9937 | 92.3227 | 92.5306
|
188
| SVK
| Slovak Republic
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 85.9548 | 86.2581 | 86.5614 | 86.8647 | 87.1680 | 87.4011 | 87.5640 | 87.7270 | 87.8899 | 88.0528 | 88.2189
|
189
| SVN
| Slovenia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 88.5144 | 88.8465 | 89.1786 | 89.5107 | 89.8428 | 90.1542 | 90.4451 | 90.7359 | 91.0267 | 91.3175 | 91.5222
|
190
| SLB
| Solomon Islands
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 61.4146 | 62.3168 | 63.2191 | 64.1213 | 65.0235 | 65.9239 | 66.8227 | 67.7214 | 68.6201 | 69.5189 | 70.3102
|
191
| SOM
| Somalia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 43.4654 | 44.1553 | 44.8452 | 45.5352 | 46.2251 | 46.5742 | 46.5825 | 46.5908 | 46.5991 | 46.6074 | 46.8807
|
192
| ZAF
| South Africa
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 57.9468 | 55.5818 | 53.2168 | 50.8518 | 48.4869 | 46.6696 | 45.4000 | 44.1304 | 42.8608 | 41.5912 | 40.8167
|
193
| ESP
| Spain
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 92.5780 | 92.7598 | 92.9416 | 93.1234 | 93.3053 | 93.4451 | 93.5429 | 93.6407 | 93.7385 | 93.8363 | 93.9169
|
194
| LKA
| Sri Lanka
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 78.8114 | 80.1997 | 81.5880 | 82.9763 | 84.3646 | 85.1424 | 85.3098 | 85.4772 | 85.6446 | 85.8119 | 86.0005
|
195
| KNA
| St. Kitts and Nevis
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | | | | | | | | | | |
|
196
| LCA
| St. Lucia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 76.2071 | 76.6559 | 77.1047 | 77.5535 | 78.0023 | 78.4670 | 78.9477 | 79.4283 | 79.9090 | 80.3896 | 80.8109
|
197
| VCT
| St. Vincent and the Grenadines
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 80.2353 | 80.1568 | 80.0783 | 79.9998 | 79.9213 | 80.0599 | 80.4157 | 80.7716 | 81.1274 | 81.4832 | 81.8252
|
198
| SDN
| Sudan
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 55.2820 | 55.5943 | 55.9067 | 56.2190 | 56.5313 | 56.8429 | 57.1537 | 57.4645 | 57.7753 | 58.0861 | 58.5275
|
199
| SUR
| Suriname
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 75.4255 | 75.4696 | 75.5136 | 75.5577 | 75.6017 | 75.7587 | 76.0286 | 76.2984 | 76.5683 | 76.8382 | 77.1397
|
200
| SWZ
| Swaziland
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 53.8789 | 49.7179 | 45.5568 | 41.3958 | 37.2348 | 34.5337 | 33.2926 | 32.0516 | 30.8105 | 29.5694 | 29.0692
|
201
| SWE
| Sweden
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 91.5264 | 91.6293 | 91.7321 | 91.8350 | 91.9378 | 92.0449 | 92.1562 | 92.2675 | 92.3787 | 92.4900 | 92.5903
|
202
| CHE
| Switzerland
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 91.8878 | 92.0540 | 92.2201 | 92.3862 | 92.5524 | 92.6969 | 92.8198 | 92.9428 | 93.0657 | 93.1886 | 93.2899
|
203
| SYR
| Syrian Arab Republic
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 81.2174 | 81.7509 | 82.2844 | 82.8180 | 83.3515 | 83.7743 | 84.0863 | 84.3983 | 84.7104 | 85.0224 | 85.3049
|
204
| TJK
| Tajikistan
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 70.3361 | 70.7030 | 71.0699 | 71.4368 | 71.8036 | 72.1060 | 72.3439 | 72.5819 | 72.8198 | 73.0577 | 73.3348
|
205
| TZA
| Tanzania
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 45.4744 | 45.5304 | 45.5864 | 45.6424 | 45.6984 | 46.2087 | 47.1731 | 48.1376 | 49.1020 | 50.0665 | 51.0071
|
206
| THA
| Thailand
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 77.7427 | 77.6903 | 77.6378 | 77.5854 | 77.5330 | 77.4242 | 77.2592 | 77.0942 | 76.9291 | 76.7641 | 76.8302
|
207
| TMP
| Timor-Leste
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 51.3413 | 52.6539 | 53.9665 | 55.2791 | 56.5917 | 57.6733 | 58.5237 | 59.3742 | 60.2246 | 61.0751 | 61.9010
|
208
| TGO
| Togo
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 65.3569 | 65.3913 | 65.4257 | 65.4601 | 65.4945 | 65.7343 | 66.1797 | 66.6251 | 67.0704 | 67.5158 | 67.9423
|
209
| TON
| Tonga
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 76.4793 | 76.9544 | 77.4294 | 77.9044 | 78.3795 | 78.8157 | 79.2130 | 79.6103 | 80.0077 | 80.4050 | 80.7107
|
210
| TTO
| Trinidad and Tobago
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 77.2095 | 76.9177 | 76.6259 | 76.3341 | 76.0423 | 76.0414 | 76.3313 | 76.6213 | 76.9113 | 77.2013 | 77.4948
|
211
| TUN
| Tunisia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 83.6930 | 84.0471 | 84.4012 | 84.7553 | 85.1094 | 85.3915 | 85.6016 | 85.8117 | 86.0218 | 86.2319 | 86.4492
|
212
| TUR
| Turkey
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 79.1531 | 79.8540 | 80.5548 | 81.2557 | 81.9566 | 82.4697 | 82.7952 | 83.1206 | 83.4460 | 83.7714 | 84.0728
|
213
| TKM
| Turkmenistan
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 70.8827 | 71.0058 | 71.1290 | 71.2522 | 71.3754 | 71.5588 | 71.8025 | 72.0461 | 72.2897 | 72.5334 | 72.8391
|
214
| UGA
| Uganda
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 34.8486 | 35.3208 | 35.7931 | 36.2653 | 36.7376 | 37.7576 | 39.3253 | 40.8930 | 42.4608 | 44.0285 | 45.4244
|
215
| UKR
| Ukraine
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 79.0672 | 79.1650 | 79.2629 | 79.3607 | 79.4585 | 79.5457 | 79.6221 | 79.6986 | 79.7751 | 79.8515 | 79.9361
|
216
| ARE
| United Arab Emirates
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 87.5913 | 87.7035 | 87.8157 | 87.9279 | 88.0401 | 88.1231 | 88.1770 | 88.2308 | 88.2847 | 88.3385 | 88.4445
|
217
| GBR
| United Kingdom
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 88.5269 | 88.7590 | 88.9910 | 89.2230 | 89.4550 | 89.6663 | 89.8571 | 90.0478 | 90.2385 | 90.4292 | 90.5929
|
218
| USA
| United States
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 86.8761 | 87.0733 | 87.2705 | 87.4676 | 87.6648 | 87.8581 | 88.0474 | 88.2368 | 88.4262 | 88.6156 | 88.7883
|
219
| URY
| Uruguay
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 85.7428 | 86.0803 | 86.4178 | 86.7553 | 87.0928 | 87.3955 | 87.6633 | 87.9312 | 88.1990 | 88.4669 | 88.6846
|
220
| UZB
| Uzbekistan
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 73.6193 | 73.7111 | 73.8029 | 73.8947 | 73.9865 | 74.1137 | 74.2764 | 74.4391 | 74.6018 | 74.7645 | 75.0196
|
221
| VUT
| Vanuatu
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 72.4460 | 73.1508 | 73.8556 | 74.5605 | 75.2653 | 75.9225 | 76.5320 | 77.1416 | 77.7512 | 78.3608 | 78.9332
|
222
| VEN
| Venezuela RB
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 81.9157 | 82.0907 | 82.2657 | 82.4407 | 82.6157 | 82.8373 | 83.1055 | 83.3737 | 83.6419 | 83.9101 | 84.1608
|
223
| VNM
| Vietnam
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 79.0844 | 79.8859 | 80.6874 | 81.4889 | 82.2904 | 82.8710 | 83.2307 | 83.5904 | 83.9501 | 84.3098 | 84.6371
|
224
| VIR
| Virgin Islands (U.S.)
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 88.8129 | 88.9670 | 89.1211 | 89.2751 | 89.4292 | 89.5893 | 89.7554 | 89.9214 | 90.0875 | 90.2536 | 90.4065
|
225
| WBG
| West Bank and Gaza
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 79.8656 | 80.2961 | 80.7265 | 81.1569 | 81.5873 | 81.9947 | 82.3790 | 82.7633 | 83.1475 | 83.5318 | 83.8733
|
226
| YEM
| Yemen Rep.
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 58.0957 | 58.8944 | 59.6932 | 60.4919 | 61.2906 | 62.0909 | 62.8929 | 63.6950 | 64.4970 | 65.2990 | 66.0860
|
227
| ZMB
| Zambia
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 35.4859 | 34.0051 | 32.5242 | 31.0433 | 29.5625 | 29.2694 | 30.1640 | 31.0586 | 31.9532 | 32.8478 | 33.9439
|
228
| ZWE
| Zimbabwe
| SP.DYN.TO65.FE.ZS
| Survival to age 65 female (% of cohort) | 40.9014 | 37.5098 | 34.1182 | 30.7266 | 27.3349 | 25.5843 | 25.4748 | 25.3652 | 25.2557 | 25.1461 | 25.8720
|